Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

2025 Jul 15, 12:10

US CPI June Data: Will Tariffs Sway the Fed's Rate Cut Decision?

2025 Jul 15, 08:10

Euroclear Warns EU: Investing Frozen Russian Assets Could Equal 'Confiscation'

Ghko B 2025 Jul 14, 16:00

Stellar Price (XLM) Surges 110% in 6 Days: How to Trade Stellar CFDs?

crypto
Frances Wang 2025 Jul 14, 16:00

Cryptos to Watch: SOLUSD Prediction, ETH Price, XRP News, Dogecoin Price

crypto cfd trading
Ghko B 2025 Jul 14, 16:00

CRWV Stock Jumps 209% in 3 Months: How to Trade CRWV Stock CFDs?

stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Latest news

Show more
Emma Rose 2025 Jul 15, 13:20

US Inflation & Tariffs: Will the Fed Hike Rates?

Emma Rose 2025 Jul 15, 12:20

Mnuchin Suggests Powell Resign from Fed Board After Chairmanship

Emma Rose 2025 Jul 15, 10:20

Trump Encouraged Ukraine to Strike Deep Inside Russia: A Shift in Strategy and Potential Escalation

liam james 2025 Jul 15, 09:20

Trump's Tariff Threat: Europe Scrambles to Avert a Full-Blown Trade War

Sophia Claire 2025 Jul 15, 06:20

US Inflation: CPI, Tariff Impact, and Federal Reserve Policy

liam james 2025 Jul 15, 06:20

Gold Price Outlook: Tariffs, Central Banks, and Supply Dynamics

Noah Lee 2025 Jul 15, 02:20

Bitcoin Breaks Consolidation, Surges Above $120K Amid Regulatory Optimism

Emma Rose 2025 Jul 15, 01:20

Kevin Hassett Emerges as Potential Fed Chair Under Trump: An Analysis

Info

Spread

0.71

Spread (%)

0.6490 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

139432099840

Shares Outstanding

1243929984

Earnings Date (Next)

2013-01-28

Div Yield

2025-06-27

Ex-Dividend Date

2025-06-13

Forward annual dividend rate

3.16

Forward annual dividend yield

0.0285

EPS

4.76

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Jul 14, 16:00

NBIS Stock Jumped over 17%: What Happened to Nebius Group?

Shares Stocks
Ghko B 2025 Jul 14, 16:00

XLM Outperforms Bitcoin: Can Stellar Price (XLM) Reach $1?

Crypto
Frances Wang 2025 Jul 14, 16:00

Crypto CFD Trading for Beginners: Ethereum CFD, XRP CFD, Solana CFD

Crypto CFD Trading
Trustpilot